AGP Limited (PSX:AGP)

Market Cap	53.09B
Revenue (ttm)	26.11B
Net Income (ttm)	3.36B
Shares Out	280.00M
EPS (ttm)	12.00
PE Ratio	15.80
Forward PE	13.86
Dividend	4.00 (2.11%)
Ex-Dividend Date	Sep 2, 2025

Volume	733,592
Average Volume	405,355
Open	189.60
Previous Close	189.60
Day's Range	186.66 - 191.40
52-Week Range	97.00 - 220.02
Beta	0.29
RSI	32.62
Earnings Date	Aug 26, 2025

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antip...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1989
• Employees: 2,143
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: AGP

Financial Performance

In 2024, AGP Limited's revenue was 25.03 billion, an increase of 33.56% compared to the previous year's 18.74 billion. Earnings were 2.67 billion, an increase of 70.58%.